Citation

Ye H, Hong YM, Jing SX, Hui Y, Juan ZX, Wei ZY. Br. J. Pharm. Sci. 2020; 56.

Copyright

(Copyright © 2020, Universidade de São Paulo, Faculdade de Ciências Farmacêuticas)

DOI

10.1590/S2175-97902020000318850

PMID

unavailable

Abstract

With the widespread use of high-efficiency antiretroviral therapy (HAART), the life expectancy of HIV-infected patients has been significantly extended. However, the metabolic complications among HIV-infected patients treated with HAART have become the most common problem in the world. It is very important to explore the incidence of dyslipidaemia and studies on the role of potential risk factors in HIV-infected Chinese patients treated with HAART are sparse. Therefore, we designed current study, to investigate the effects of therapeutic intervention and continuous information support on the lifestyle of HIV/AIDS patients with dyslipidaemia. Three hundred and six HIV/AIDS patients admitted to the AIDS clinic in Beijing from January 2016 to January 2017 were recruited and assigned into two groups: the treatment group (n=64) and the control group (n=64). The median age of the participants was 38.8±11.0 years (range 20-75 years). The prevalence of dyslipidemia in control and treatment group was (59/64) 92.2% and (53/64) 82.8%, respectively. In this study, low HDL-cholesterol (HDLC) led to abnormalities 47/64 (73.3%) in the control group and 35/64 (54.7%) in HAART-treatment group. Additionally, HAART group showed higher triglyceride, total cholesterol, and low-density lipoprotein (246.1±171.8, 1.73±1.61 mmol/L, 4.46±1.1 mmol/L, 2.54±0.74 mmol/L). In multivariate analysis, gender, marital status, high BMI, dietary habits and physical activity were potential risk factors for dyslipidemia in HIV-infected Chinese patients. In this study, we reported high prevalence dyslipidemiain two HIV infected groups. We suggest that the appropriate diagnosis should be performed for analyzing the metabolic complications in HIV-infected Chinese patients. Further studies are very important to understand the role of potential risk factors in metabolic complications. © 2020, Faculdade de Ciencias Farmaceuticas (Biblioteca). All rights reserved.

Language: en

Keywords

adult; human; suicide; female; male; depression; physical activity; HIV; life expectancy; obesity; major clinical study; controlled study; cholesterol blood level; cholesterol; acquired immune deficiency syndrome; hypercholesterolemia; hypertension; hyperlipidemia; Human immunodeficiency virus; virus load; Article; dyslipidemia; waist circumference; HAART; Lipid; Dyslipidaemia; Metabolic Complications